The A.R.R.E.S.T.® Contact Lens Study
NCT: NCT06878118 · ACTIVE_NOT_RECRUITING
Brief Summary
The goal of this clinical trial is to learn if contact lenses using Active Reconfiguration in Retinal Encoding of Spatio-Temporal (A.R.R.E.S.T.®) signal technology works to slow down the rate of myopia progression compared to single vision contact lenses in myopic children. The main questions it aims to answer are: Do contact lenses using A.R.R.E.S.T.® technology slow down the rate of axial length growth? Do contact lenses using A.R.R.E.S.T.® technology slow down the rate of increase in myopic refractive error? Researchers will compare contact lenses using A.R.R.E.S.T.® technology to a single vision contact lens. Participants will: Be randomly allocated to wear either contact lenses using A.R.R.E.S.T.® technology or single vision contact lenses. Visit the clinic on seven occasions over a 12 month period.
Frequently Asked Questions
What is The A.R.R.E.S.T.® Contact Lens Study?
The A.R.R.E.S.T.® Contact Lens Study is a clinical trial registered under NCT06878118. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06878118?
The current status of NCT06878118 (The A.R.R.E.S.T.® Contact Lens Study) is: ACTIVE_NOT_RECRUITING.
When did The A.R.R.E.S.T.® Contact Lens Study start?
The A.R.R.E.S.T.® Contact Lens Study started on 2025-07-06.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.